Jefferies says its analysis of Mako Surgical (MAKO +4.2%) points to considerable upside . After...

|About: MAKO Surgical Corp. (MAKO)|By:, SA News Editor

Jefferies says its analysis of Mako Surgical (MAKO +4.2%) points to considerable upside . After reviewing its free cash flow yield and historical valuation relative to Intuitive Surgical (ISRG +1.2%) and other traditional medical device names, Jefferies believes the shares are significantly undervalued. The firm reiterates a buy at current levels and maintains an Overweight rating on the stock with a $49 price target.